您的购物车当前为空
别名 异四氢烟酸, 1,2,3,6-tetrahydro-4-pyridinecarboxylic acid hydrochloride
Isoguvacine hydrochloride (1,2,3,6-tetrahydro-4-pyridinecarboxylic acid hydrochloride) 是 GABA 受体激动剂。它与大鼠突触皮质膜结合并激活 α1β2γ2S、α2β2γ2S、α3β2γ2S、α5β2γ2S 和 ρ1 亚基 GABAA 受体。


为众多的药物研发团队赋能,
让新药发现更简单!
Isoguvacine hydrochloride (1,2,3,6-tetrahydro-4-pyridinecarboxylic acid hydrochloride) 是 GABA 受体激动剂。它与大鼠突触皮质膜结合并激活 α1β2γ2S、α2β2γ2S、α3β2γ2S、α5β2γ2S 和 ρ1 亚基 GABAA 受体。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 119 | In stock | |
| 10 mg | ¥ 163 | In stock | |
| 25 mg | ¥ 280 | In stock | |
| 50 mg | ¥ 488 | In stock | |
| 100 mg | ¥ 738 | In stock | |
| 500 mg | ¥ 1,870 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 111 | In stock |
Isoguvacine hydrochloride 相关产品
| 产品描述 | Isoguvacine hydrochloride (1,2,3,6-tetrahydro-4-pyridinecarboxylic acid hydrochloride) is a GABA receptor agonist. Isoguvacine hydrochloride binds to rat synaptic cortical membranes and activates α1β2γ2S, α2β2γ2S, α3β2γ2S, α5β2γ2S, and ρ1 subunit GABAA receptors. |
| 体外活性 | 50 μM Isoguvacine可阻断6个器官型海马切片培养物中的2个的癫痫样活动。Isoguvacine 呈剂量依赖性地抑制低镁引发的癫痫样事件[2]。Isoguvacine与小鼠前脑突触膜制剂结合,并能特异性地结合到GABA、muscimol和bicuculline,但不与picrotoxin或二氨基丁酸结合。Isoguvacine 结合水平在小脑、皮层和海马中观察到最高[3]。 |
| 别名 | 异四氢烟酸, 1,2,3,6-tetrahydro-4-pyridinecarboxylic acid hydrochloride |
| 分子量 | 163.6 |
| 分子式 | C6H10ClNO2 |
| CAS No. | 68547-97-7 |
| Smiles | Cl.OC(=O)C1=CCNCC1 |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 90 mg/mL (550.12 mM), Sonication is recommended. DMSO: 20 mg/mL (122.25 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (12.22 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO/H2O
| ||||||||||||||||||||||||||||||||||||
评论内容